Mark Bevan, PhD, is a Professor of Neuroscience at Northwestern University’s Feinberg School of Medicine. His research focuses on the basal ganglia and their dysregulation in psychomotor disorders like Parkinson’s disease and Huntington’s disease. His laboratory utilizes a range of molecular, electrophysiological, optogenetic, chemogenetic, and imaging approaches. In recent years, his research team has contributed to our understanding of dopaminergic modulation mechanisms and circuit consequences of dopamine loss in Parkinson’s disease. Dr. Bevan received his PhD from the University of Manchester and undertook postdoctoral training at the University of Oxford and the University of Tennessee, supported in part by an Advanced Training Fellowship from the Wellcome Trust. In 2012, Dr. Bevan received a Jacob Javits Neuroscience Investigator Award from NIH-NINDS, and in 2016 and 2018 he co-chaired the Basal Ganglia Gordon Research Conference. Dr. Bevan also directs an NIH-NINDS-funded training program in motor control mechanisms in health and disease.